INS and obesity due to melanocortin 4 receptor deficiency: This is consistent with previous reports showing that GLP-1 levels and secretion increased during obesity development protected against glucose intolerance induction, and GLP-1 treatment improved insulin sensitivity in rodents fed an HFD [40–42].